National Heart, Lung, and Blood Institute; Notice of Meeting, 52142-52143 [2020-18440]

Download as PDF 52142 Federal Register / Vol. 85, No. 164 / Monday, August 24, 2020 / Notices Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute Of Arthritis And Musculoskeletal And Skin Diseases Notice of Meeting jbell on DSKJLSW7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. The meeting will be open to the public online as indicated below, with attendance limited to online participation only. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. Date: September 1, 2020. Open: 10:00 a.m. to 12:45 p.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Bethesda, MD, (Virtual Meeting). Virtual Access: The meeting will be videocast and can be accessed from the NIH Videocast https://videocast.nih.gov. Please note, the link to the videocast meeting will be posted within a week of the meeting date. Any member of the public may submit written comments no later than 15 days after the meeting. Closed: 2:00 p.m.–3:30 p.m. Agenda: To Review and Evaluate Grant Applications. Contact Person: Melinda Nelson, Acting Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Grants Management Branch, 45 Center Drive, Natcher Building, Room 5A49, Bethesda, MD 20892, (301) 594–3535, mn23z@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Any interested person may file written comments with the committee by forwarding the statement to the VerDate Sep<11>2014 16:31 Aug 21, 2020 Jkt 250001 Dated: August 18, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–18441 Filed 8–21–20; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel Small Business: Low Vision, Ocular Biomedical and Bioengineering Technology Development. Date: September 14, 2020. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Susan Gillmor, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, (240) 762–3076, susan.gillmor@nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel NIH Research Enhancement Award (R15) in Oncological Sciences. Date: September 16, 2020. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Svetlana Kotliarova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, Bethesda, MD 20892, (301) 594–7945, kotliars@mail.nih.gov. Fmt 4703 [FR Doc. 2020–18439 Filed 8–21–20; 8:45 am] Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review Notice of Closed Meetings Frm 00058 Dated: August 18, 2020. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES PO 00000 (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council. The meeting will be open to the public as indicated below and held as a virtual meeting. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Heart, Lung, and Blood Advisory Council. Date: September 15, 2020. Open: 8:00 a.m. to 11:00 a.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Room 206–Q, Bethesda, MD 20892, (Virtual Meeting). Open: 1:30 p.m. to 4:00 p.m. Agenda: To discuss program policies and issues. Place: National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Room 206–Q, Bethesda, MD 20892, (Virtual Meeting). Virtual Access: The meeting will be videocast and can be accessed from the NIH Videocast. Please note, the link to the videocast meeting will be posted within a week of the meeting date on the NHLBI Council website: https://www.nhlbi.nih.gov/ about/advisory-and-peer-review-committees/ advisory-council. Contact Person: Laura K. Moen, Ph.D., Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892, 301–435–0260, moenl@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when E:\FR\FM\24AUN1.SGM 24AUN1 Federal Register / Vol. 85, No. 164 / Monday, August 24, 2020 / Notices applicable, the business or professional affiliation of the interested person. Any member of the public may submit written comments no later than 15 days after the meeting. Information is also available on the Institute’s/Center’s home page: www.nhlbi.nih.gov/meetings/nhlbac/ index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) Dated: August 18, 2020. Ronald J. Livingston, Jr., Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2020–18440 Filed 8–21–20; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF THE INTERIOR Bureau of Safety and Environmental Enforcement [Docket ID BSEE–2020–0009; EEEE500000 20XE1700DX EX1SF0000.EAQ000; OMB Control Number 1014–0024] Agency Information Collection Activities; Plans and Information Bureau of Safety and Environmental Enforcement, Interior. ACTION: Notice of information collection; request for comment. AGENCY: In accordance with the Paperwork Reduction Act (PRA) of 1995, the Bureau of Safety and Environmental Enforcement (BSEE) proposes to renew an information collection. DATES: Interested persons are invited to submit comments on or before October 23, 2020. ADDRESSES: Send your comments on this information collection request (ICR) by either of the following methods listed below: • Electronically go to https:// www.regulations.gov. In the Search box, enter BSEE–2020–0009 then click search. Follow the instructions to submit public comments and view all related materials. We will post all comments. • Email kye.mason@bsee.gov, fax (703) 787–1546, or mail or hand-carry comments to the Department of the Interior; Bureau of Safety and Environmental Enforcement; Regulations and Standards Branch; ATTN: Nicole Mason; 45600 Woodland Road, Sterling, VA 20166. Please jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 16:31 Aug 21, 2020 Jkt 250001 reference OMB Control Number 1014– 0024 in the subject line of your comments. To request additional information about this ICR, contact Nicole Mason by email at kye.mason@bsee.gov or by telephone at (703) 787–1607. SUPPLEMENTARY INFORMATION: In accordance with the PRA and 5 CFR 1320.8(d)(1), all information collections require approval under the PRA. We may not conduct, or sponsor and you are not required to respond to a collection of information unless it displays a currently valid OMB control number. As part of our continuing effort to reduce paperwork and respondent burdens, we invite the public and other Federal agencies to comment on new, proposed, revised, and continuing collections of information. This helps us assess the impact of our information collection requirements and minimize the public’s reporting burden. It also helps the public understand our information collection requirements and provide the requested data in the desired format. We are especially interested in public comment addressing the following: (1) Whether or not the collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) The accuracy of our estimate of the burden for this collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) How might the agency minimize the burden of the collection of information on those who are to respond, including using appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of response. Comments that you submit in response to this notice are a matter of public record. We will include or summarize each comment in our request to OMB to approve this ICR. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we FOR FURTHER INFORMATION CONTACT: PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 52143 cannot guarantee that we will be able to do so. Abstract: Regulations implementing plans and information responsibilities are under 30 CFR part 250, subpart B, and are among those delegated to BSEE. This request also covers any related Notices to Lessees and Operators (NTLs) that BSEE issues to clarify, supplement, or provide additional guidance on some aspects of our regulations. For § 250.282—Post-Approval Requirements for the EP, DPP, and DOCD: While the information is submitted to BOEM, BSEE analyzes and evaluates the information and data collected under this section of subpart B to verify that an ongoing/completed OCS operation is/was conducted in compliance with established environmental standards placed on the activity. For §§ 250.287–295—Deepwater Operations Plan (DWOP): BSEE analyzes and evaluates the information and data collected under this section of subpart B to ensure that planned operations are safe; will not adversely affect the marine, coastal, or human environment; and will conserve the resources of the OCS. We use the information to make an informed decision on whether to approve the proposed DWOPs, or whether modifications are necessary without the analysis and evaluation of the required information. Title of Collection: 30 CFR 250, Subpart B, Plans and Information. OMB Control Number: 1014–0024. Form Number: None. Type of Review: Extension of a currently approved collection. Respondents/Affected Public: Potential respondents include Federal OCS oil, gas, and sulfur lessees and/or operators and holders of pipeline rightsof-way. Total Estimated Number of Annual Respondents: Currently there are approximately 60 Oil and Gas Drilling and Production Operators in the OCS. Not all the potential respondents will submit information in any given year, and some may submit multiple times. Total Estimated Number of Annual Responses: 31. Estimated Completion Time per Response: Varies from 50 hours to 2,200 hours, depending on activity. Total Estimated Number of Annual Burden Hours: 44,458. Respondent’s Obligation: Most responses are mandatory; while some are required to obtain or retain a benefit. Frequency of Collection: Submissions are generally on occasion. Total Estimated Annual Nonhour Burden Cost: $68,381. E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 85, Number 164 (Monday, August 24, 2020)]
[Notices]
[Pages 52142-52143]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18440]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Heart, 
Lung, and Blood Advisory Council.
    The meeting will be open to the public as indicated below and held 
as a virtual meeting. Individuals who plan to view the virtual meeting 
and need special assistance or other reasonable accommodations to view 
the meeting, should notify the Contact Person listed below in advance 
of the meeting.

    Name of Committee: National Heart, Lung, and Blood Advisory 
Council.
    Date: September 15, 2020.
    Open: 8:00 a.m. to 11:00 a.m.
    Agenda: To discuss program policies and issues.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Room 206-Q, Bethesda, MD 20892, (Virtual Meeting).

    Open: 1:30 p.m. to 4:00 p.m.
    Agenda: To discuss program policies and issues.
    Place: National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Room 206-Q, Bethesda, MD 20892, (Virtual Meeting).

    Virtual Access: The meeting will be videocast and can be 
accessed from the NIH Videocast. Please note, the link to the 
videocast meeting will be posted within a week of the meeting date 
on the NHLBI Council website: https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council.
    Contact Person: Laura K. Moen, Ph.D., Director, Division of 
Extramural Research Activities, National Heart, Lung, and Blood 
Institute, National Institutes of Health, Rockledge I, 6705 
Rockledge Drive, Bethesda, MD 20892, 301-435-0260, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when

[[Page 52143]]

applicable, the business or professional affiliation of the 
interested person. Any member of the public may submit written 
comments no later than 15 days after the meeting.
    Information is also available on the Institute's/Center's home 
page: www.nhlbi.nih.gov/meetings/nhlbac/index.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: August 18, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-18440 Filed 8-21-20; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.